Senior insider sale
EVP, Chief Financial Officer at GILEAD SCIENCES, INC. — senior position signals high conviction
$1.72M
12K shares
What this filing means
DICKINSON ANDREW D plans to sell 12K shares of GILEAD SCIENCES, INC. valued at approximately $1.72M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/15/2026ACC: 0001950047-26-004577
Officer· EVP, Chief Financial Officer
Since Nov 2019
12K
Shares to sell
$1.72M
Approx. market value
3K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Performance Shares
Not Applicable
1/24/2023
3KTotal acquired3K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/24/2023 | Performance Shares Not Applicable | 3K | — |
| Total | 3K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
3K
Market value
$422.9K
4/15/2026
—Completed
Units to sell
3K
Market value
$432.7K
3/16/2026
—Completed
Units to sell
3K
Market value
$463.3K
2/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3K
Market value
$396.8K
5/15/2026
Total
Units
12K
Value
$1.72M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/15/2026 | 3K | $422.9K | — | Completed |
3/16/2026 | 3K | $432.7K | — | Completed |
2/17/2026 | 3K | $463.3K | — | Completed |
| Planned — Approximate Date | ||||
5/15/2026 | 3K | $396.8K | NASDAQ | Planned |
| Total | 12K | $1.72M | ||